WhitTier Trust Company’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.32K Buy
39
+9
+30% +$932 ﹤0.01% 1193
2026
Q1
$3.15K Sell
30
-1
-3% -$103 ﹤0.01% 1211
2025
Q4
$3.34K Sell
31
-11
-26% -$1.27K ﹤0.01% 1121
2025
Q3
$5.18K Sell
42
-2
-5% -$238 ﹤0.01% 1069
2025
Q2
$5.39K Sell
44
-2
-4% -$228 ﹤0.01% 1202
2025
Q1
$4.66K Hold
46
﹤0.01% 1188
2024
Q4
$4.25K Hold
46
﹤0.01% 1166
2024
Q3
$4.45K Buy
46
+12
+35% +$1.08K ﹤0.01% 1135
2024
Q2
$2.92K Sell
34
-1
-3% -$84 ﹤0.01% 1137
2024
Q1
$2.89K Buy
+35
New +$2.56K ﹤0.01% 1099

Other funds holding EHC

WhitTier Trust Company's EHC Position: Q2 2026 in Review

WhitTier Trust Company increased its Encompass Health (EHC) stake by 30% in Q2 2026, buying an estimated $932 and bringing the position to 39 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

WhitTier Trust Company first reported a position in EHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.39K in Q2 2025. 274 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • WhitTier Trust Company held 39 shares of Encompass Health worth $4.32K as of Q2 2026.
  • WhitTier Trust Company bought 9 Encompass Health shares in Q2 2026, an estimated $932.
  • Encompass Health made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #1193 holding.
  • WhitTier Trust Company first reported a position in Encompass Health in Q1 2024 and has held it in 10 quarters since.
  • WhitTier Trust Company's Encompass Health position peaked at $5.39K in Q2 2025.
  • 274 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.